Brief

The List of Spurious Drugs for October 2024, published by CDSCO, highlights three pharmaceutical productsPantoprazole & Domperidone Capsules, Cefixime Tablets, and Rosuvastatin Tablets—as potentially spurious. The manufacturers listed on the labels have denied producing these batches, raising concerns about counterfeit medications in circulation. Investigations are ongoing to confirm their authenticity and determine further regulatory actions.

This content is restricted.

Highlights content goes here...

This content is restricted.

Central Drugs Standard Control Organization (CDSCO)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies